Arkema (FR:AKE)
:AKE
Want to see FR:AKE full AI Analyst Report?
Top Page
Arkema
(AKE)
Select Model
Select Model
Rating:59Neutral
Price Target:
€66.00
▲(5.94% Upside)
Action:Reiterated
Date:05/09/26
The score is held back primarily by weakened financial performance (margin and earnings compression to near-breakeven), partially offset by a solid balance sheet and positive free cash flow. Technicals are supportive with the price above major moving averages and positive MACD, while valuation is mixed with a high dividend yield but an elevated P/E.
Positive Factors
Balance sheet strength
Arkema’s sizable equity base and moderate leverage provide durable financial flexibility. With total debt around €5.07bn against €6.16bn equity, the company can fund capex, R&D and cyclical troughs without immediate refinancing pressure, supporting long-term investment and resilience.
Negative Factors
Thin net profitability
Net margin near 0.5% leaves limited buffer against raw-material or demand shocks. Thin profitability constrains retained earnings and reduces capacity to absorb cyclical downturns, undermining sustainable returns and making operational improvements or pricing recovery urgent to restore durable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Arkema’s sizable equity base and moderate leverage provide durable financial flexibility. With total debt around €5.07bn against €6.16bn equity, the company can fund capex, R&D and cyclical troughs without immediate refinancing pressure, supporting long-term investment and resilience.
Read all positive factors
Arkema (AKE) vs. iShares MSCI France ETF (EWQ)
Market Cap
€4.58B
Dividend Yield7.05%
Average Volume (3M)234.51K
Price to Earnings (P/E)40.4
Beta (1Y)1.44
Revenue Growth-7.46%
EPS Growth-87.36%
CountryFR
Employees21,150
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.55
Shares Outstanding76,060,830
10 Day Avg. Volume237,321
30 Day Avg. Volume234,507
Financial Highlights & Ratios
PEG Ratio-0.77
Price to Book (P/B)0.65
Price to Sales (P/S)0.43
P/FCF Ratio11.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€61.67Price Target Upside-1.02% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)4.87
Revenue Forecast (FY)€9.16B
Arkema Business Overview & Revenue Model
Company Description
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for constru...
How the Company Makes Money
Arkema makes money primarily by manufacturing and selling specialty chemicals and advanced materials to industrial customers under long-term supply relationships and recurring purchasing cycles tied to customer production volumes. Its revenue mode...
Arkema Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
68
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.87B | 9.07B | 9.54B | 9.51B | 11.55B | 9.52B |
| Gross Profit | 1.56B | 1.61B | 1.94B | 1.96B | 2.58B | 2.14B |
| EBITDA | 918.70M | 1.25B | 1.31B | 1.33B | 1.82B | 2.27B |
| Net Income | 41.30M | 63.00M | 354.00M | 402.00M | 965.00M | 1.31B |
Balance Sheet | ||||||
| Total Assets | 14.22B | 14.24B | 15.21B | 14.52B | 13.51B | 12.30B |
| Cash, Cash Equivalents and Short-Term Investments | 1.73B | 2.20B | 2.01B | 2.04B | 1.59B | 2.29B |
| Total Debt | 5.07B | 5.36B | 4.55B | 4.28B | 3.26B | 2.76B |
| Total Liabilities | 7.88B | 8.01B | 7.45B | 7.06B | 6.17B | 5.95B |
| Stockholders Equity | 6.16B | 6.04B | 7.53B | 7.20B | 7.30B | 6.30B |
Cash Flow | ||||||
| Free Cash Flow | 400.00M | 337.00M | 353.00M | 622.00M | 766.00M | 152.00M |
| Operating Cash Flow | 983.60M | 973.00M | 1.12B | 1.26B | 1.50B | 915.00M |
| Investing Cash Flow | -576.10M | -616.00M | -940.00M | -1.35B | -2.34B | 473.00M |
| Financing Cash Flow | 162.80M | -262.00M | -207.00M | 516.00M | 168.00M | -652.00M |
Arkema Technical Analysis
Positive
62.30
Price Trends
59.25
Positive
57.43
Positive
56.06
Positive
Market Momentum
0.51
Positive
45.67
Neutral
14.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Positive. The current price of 62.3 is below the 20-day moving average (MA) of 62.39, above the 50-day MA of 59.25, and above the 200-day MA of 56.06, indicating a neutral trend. The MACD of 0.51 indicates Positive momentum. The RSI at 45.67 is Neutral, neither overbought nor oversold. The STOCH value of 14.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:AKE.
Arkema Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €102.21B | 13.47 | 13.87% | 2.06% | -0.43% | 6.33% | |
59 Neutral | €4.58B | 40.39 | 2.27% | 7.05% | -7.46% | -87.36% | |
57 Neutral | €124.40M | -1.33 | -19.12% | ― | 90.91% | -22.05% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | €100.82M | -2.65 | -22.98% | ― | -20.58% | -41.43% |
* General Sector Average
FR:AKE
Arkema
61.70
-1.28
-2.03%
FR:AI
Air Liquide
179.72
-1.71
-0.94%
FR:ALCRB
Carbios SA
7.40
1.30
21.31%
FR:ALAFY
AFYREN
2.63
0.51
24.06%
FR:ALDUB
Encres Dubuit SA
2.04
-0.80
-28.17%
FR:MLPRX
Parx Materials NV
0.58
0.39
205.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.